CLINICAL ROLE -
In their concluding remarks, Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, summarize the key takeaways and highlight the persistent unmet needs in the management of hepatic encephalopathy.
Heterogeneity Observed in Reporting on Drug-Drug Interactions With Proton Pump Inhibitors
Exploring the Connection Between Orange Peels, Gut Metabolism, and Heart Health
FDA Approves Vedolizumab for Maintenance Therapy to Treat Crohn Disease
Low Melatonin in the Gut Can Increase Risk of Neurological Disorders
J&J Submits sBLA To FDA for Guselkumab in Ulcerative Colitis
Environmental Toxin BPA Affects Gut Microbial Communities in Children